ow dose radiotherapy to bilateral lungs for COVID-19 pneumonia - A Prospective Single Centre Study

Kolhapur Cancer Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with RT-PCR proven COVID-19 infection with moderate to severe pneumonia with National Early Warning Score [NEWS] 5 or more.

•1.Patients requiring mechanical ventilation
•2.Prior lobectomy or pneumonectomy
•3.Prior thoracic radiotherapy
•4.Prior chemotherapy or other systemic therapy with potential for pulmonary toxicity
•5.Prior radio-sensatization
•6.Severe pre-existing heart disease e.g. New York Heart Association [NYHA] functional class 3 or higher, congestive cardiac failure
•7.History of Bone marrow or solid organ transplant
•8.Known history of autoimmune collagen vascular disease
•9.Known hereditory syndrome with increased sensitivity to ionizing radiation e.g. ataxia-telengiectasia or Fanconi anemia
•10.Pregnancy
•11.Inability to lie down supine and flat for radiotherapy
•12.Inability to provide informed consent or lack of authorized representative who can provide informed consent.

发起方

Kolhapur Cancer Centre